New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 10, 2012
07:10 EDTCVS, GDOT, AXPGreen Dot partner CVS may soon offer AmEx prepaid cards, says Jefferies
Jefferies said its channel checks indicate CVS Caremark (CVS), one of Green Dot's (GDOT) largest distribution partners, may offer as soon as next week American Express' (AXP) new prepaid cards. The firm believes the potential loss of share at CVS could represent incremental headline risk for Green Dot and lowered its price target for Green Dot shares to $13 from $17. Jefferies also dropped its 2012 and 2013 earnings estimates for Green Dot citing American Express' recent penetration of Green Dot's key distribution partners Wal-Mart (WMT) and CVS.
News For GDOT;CVS;AXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 16, 2014
08:21 EDTCVSCVS Health sees tobacco exit continuing to dilute FY15 profits, as expected
CVS Health sees an annual impact from its tobacco exit of $2B in lost revenues, including $1.5B from tobacco and the rest from basket, and 17c per share impact to FY15 EPS, compared to about 8c in 2014. CVS sees an incremental impact in 2015 from its tobacco exit of $1.1B in lost revenues and between 8c-9c per share in EPS, which will be front-half loaded. CVS noted that the year-over -year impact from the exit will be fully wrapped by Q4. CVS said the cadence of its 2015 profit growth should be significantly back-half weighted, citing the tobacco exit, the timing of break-open generics, the benefits from Red Oak Sourcing and other factors.
08:17 EDTCVSCVS Health sees FY15 PBM revenue up 11%-12.25%
Subscribe for More Information
08:00 EDTCVSCVS Health sees FY15 retail SSS down 0.5% to up 0.75%
Subscribe for More Information
07:58 EDTCVSCVS Health sees FY15 revenue up 7%-8.25%, consensus $146.09B
Subscribe for More Information
07:55 EDTCVSCVS Health backs FY14 adjusted EPS view $4.47-$4.50, consensus $4.50
Subscribe for More Information
07:36 EDTCVSCVS Health sees FY15 free cash flow $5.9B-$6.2B
CVS Health expects to generate free cash flow of $5.9B-$6.2B in 2015, and cash from operations of $7.6B-$7.9B in 2015. This guidance assumes the completion of $6B in share repurchases during 2015. "We've established a solid track record of delivering on our promises, and our results prove that out. Looking ahead, we are targeting solid, long-term enterprise growth and expect to generate a significant amount of cash that will be available to enhance returns. Some of that cash will be used to invest in the business, such as through strategic, bolt-on acquisitions that drive continued share gains. The rest will be returned to our shareholders through dividends and value-enhancing share repurchases," said CFO Dave Denton.
07:35 EDTCVSCVS Health adds $10B to share repurchase plan, boosts dividend 27%
CVS Health announced that its board of directors approved a 27% increase in its quarterly cash dividend, to 35c per share on the common stock of the company. This increase translates to $1.40 per share annually, up 30c per share, and keeps the company solidly on track to meet its 2018 dividend payout ratio target of 35%. The quarterly dividend is payable on February 2 to holders of record on January 22. In addition, the company announced that its board of directors approved a new share repurchase program for up to $10B of the company's outstanding common stock, which is effective immediately and is expected to be completed over a multi-year period, permits the company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. Combined with approximately $2.7B that remains on the share repurchase program approved by the board of directors in December of 2013, this new $10B share repurchase authorization makes available a total of approximately $12.7B for share repurchases.
07:33 EDTCVSCVS Health sees FY15 adjusted EPS $5.05-$5.19, consensus $5.11
07:32 EDTCVSCVS Health announces $10B share repurchase plan, boosts dividend 27%
December 15, 2014
12:26 EDTCVSCVS Health volatility increases into analyst day
Subscribe for More Information
12:07 EDTAXPAmerican Express reports November write-off rate 1.4% vs. 1.3% last month
Subscribe for More Information
December 12, 2014
15:19 EDTGDOTGreen Dot files to sell 6.13M shares of Class A common stock for holders
Subscribe for More Information
14:56 EDTGDOTGreen Dot requests withdrawal of registration statement
The company requests withdrawal of the Registration Statement, File No. 333-200873, because it was inadvertently filed as form type S-3 instead of form type S-3ASR. The company intends to file a new automatic shelf registration statement with the proper EDGAR codes to identify it as a filing on form type S-3ASR shortly after submitting this request.
06:14 EDTGDOTGreen Dot files to sell 6.13M shares for holders
December 11, 2014
10:02 EDTAXPAmerican Express, Delta Air Lines announce multi-year partnership extension
Subscribe for More Information
05:53 EDTCVSCVS Health to host analyst day
Subscribe for More Information
December 10, 2014
12:50 EDTAXPAmerican Express says company was impacted by modest growth of global economy
Subscribe for More Information
10:00 EDTCVSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with an Underperform at Longbow... AutoZone (AZO) initiated with a Buy at Nomura... C.H. Robinson (CHRW) initiated with a Neutral at Nomura... CSX (CSX) initiated with a Buy at Nomura... CVS Health (CVS) initiated with a Neutral at Citigroup... Canadian National (CNI) initiated with a Neutral at Nomura... Carrizo Oil & Gas (CRZO) initiated with a Buy at Canaccord... CenterPoint Energy (CNP) initiated with a Neutral at Nomura... Con-way (CNW) initiated with a Neutral at Nomura... Cornerstone OnDemand (CSOD) initiated with a Buy at BofA/Merrill... Depomed (DEPO) initiated with an Outperform at RBC Capital... Dollar General (DG) initiated with a Buy at Citigroup... Dollar Tree (DLTR) initiated with a Neutral at Citigroup... Dynagas LNG (DLNG) initiated with a Buy at ABN Amro... EMC (EMC) initiated with a Neutral at JPMorgan... Energy Focus (EFOI) initiated with a Buy at Roth Capital... Expeditors (EXPD) initiated with a Neutral at Nomura... GasLog (GLOG) initiated with a Buy at ABN Amro... Genesee & Wyoming (GWR) initiated with a Neutral at Nomura... Golar LNG (GLNG) initiated with a Sell at ABN Amro... HII Technologies (HIIT) initiated with a Buy at Roth Capital... Hudbay Minerals (HBM) initiated with an Overweight at Barclays... J.B. Hunt (JBHT) initiated with a Buy at Nomura... Kansas City Southern (KSU) initiated with a Buy at Nomura... Kroger (KR) initiated with a Buy at Citigroup... Lear (LEA) initiated with a Buy at Northcoast... Lundin Mining (LUNMF) initiated with an Overweight at Barclays... NetApp (NTAP) initiated with a Neutral at JPMorgan... Norfolk Southern (NSC) initiated with a Neutral at Nomura... PROS (PRO) initiated with an Outperform at Pacific Crest... Qlik Technologies (QLIK)initiated with a Buy at BofA/Merrill... Rentokil (RTOKY) initiated with a Neutral at UBS... Revolution Lighting (RVLT) initiated with a Buy at Roth Capital... ServiceNow (NOW) initiated with a Buy at BofA/Merrill... Stratasys (SSYS) initiated with a Neutral at Longbow... Suburban Propane (SPH) initiated with a Hold at Stifel... Tableau (DATA) initiated with a Buy at BofA/Merrill... Teekay LNG (TGP) initiated with a Buy at ABN Amro... Tessera (TSRA) initiated with a Buy at Sidoti... Union Pacific (UNP) initiated with a Buy at Nomura... Viper Energy (VNOM) initiated with a Buy at Stifel... Visteon (VC) initiated with a Buy at Northcoast... Walgreen (WAG) initiated with a Buy at Citigroup... Werner (WERN) initiated with a Neutral at Nomura.
06:14 EDTCVSCVS Health initiated with a Neutral at Citigroup
Citigroup started shares of CVS Health with a Neutral rating and $99 price target saying much of the company's growth is priced into shares at current levels.
December 8, 2014
11:30 EDTCVSLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use